Home › FDA Advisory Panel To Re-Evaluate Diabetes Drug Avandia In June
 

Keywords :   


FDA Advisory Panel To Re-Evaluate Diabetes Drug Avandia In June

2013-04-14 18:20:38| Biotech - Topix.net

Three years after restricting sales of Avandia , the US Food and Drug Administration has scheduled a health advisory panel to re-evaluate the safety of the diabetes drug, various media outlets reported on Friday.

Tags: june panel drug advisory

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
05.11Boeing strike ends as workers back 38% pay rise deal
05.11Tropical Storm Rafael Public Advisory Number 6A
05.11Summary for Tropical Storm Rafael (AT3/AL182024)
05.11Tropical Storm Rafael Graphics
05.11Atlantic Tropical Weather Outlook
05.11Eastern North Pacific Tropical Weather Outlook
05.11Tropical Storm Rafael Graphics
05.11Tropical Storm Rafael Forecast Discussion Number 6
More »